142 related articles for article (PubMed ID: 15136666)
1. Paraneoplastic opsoclonus/myoclonus: B cells, T cells, both, or neither?
Posner JB
Neurology; 2004 May; 62(9):1466-7. PubMed ID: 15136666
[No Abstract] [Full Text] [Related]
2. Cross-reactive T-cell receptors in tumor and paraneoplastic target tissue.
Pellkofer HL; Voltz R; Goebels N; Hohlfeld R; Dornmair K
Arch Neurol; 2009 May; 66(5):655-8. PubMed ID: 19433667
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid γδ T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Pranzatelli MR; Allison TJ; McGee NR; Tate ED
Clin Exp Immunol; 2018 Jul; 193(1):103-112. PubMed ID: 29485697
[TBL] [Abstract][Full Text] [Related]
4. Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin.
Pranzatelli MR; Hyland K; Tate ED; Arnold LA; Allison TJ; Soori GS
J Child Neurol; 2004 Dec; 19(12):919-24. PubMed ID: 15704863
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
6. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes.
Pranzatelli MR; Travelstead AL; Tate ED; Allison TJ; Moticka EJ; Franz DN; Nigro MA; Parke JT; Stumpf DA; Verhulst SJ
Neurology; 2004 May; 62(9):1526-32. PubMed ID: 15136676
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
8. Immunological mechanisms in paraneoplastic peripheral neuropathy.
Antoine JC
Clin Rev Allergy Immunol; 2000 Aug; 19(1):61-72. PubMed ID: 11064827
[No Abstract] [Full Text] [Related]
9. No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.
de Beukelaar JW; Milikan JC; Verjans GM; de Graaf MT; van Norden Y; Lamers CH; van den Bent MJ; Bromberg JE; Hulsenboom E; Sintnicolaas K; Gratama JW; Sillevis Smitt PA
J Neurol; 2009 Feb; 256(2):279-82. PubMed ID: 19252764
[No Abstract] [Full Text] [Related]
10. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Travelstead AL; Barbosa J; Bergamini RA; Civitello L; Franz DN; Greffe BS; Hanson RD; Hurwitz CA; Kalinyak KA; Kelfer H; Khakoo Y; Mantovani JF; Nicholson SH; Sanders JM; Wegner S
J Pediatr Hematol Oncol; 2006 Sep; 28(9):585-93. PubMed ID: 17006265
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus.
Pranzatelli MR; Travelstead AL; Tate ED; Allison TJ; Lee ND; Fisher J; Jasty R
J Pediatr Hematol Oncol; 2004 Nov; 26(11):718-23. PubMed ID: 15543005
[TBL] [Abstract][Full Text] [Related]
12. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity.
Pranzatelli MR; Travelstead AL; Tate ED; Allison TJ; Verhulst SJ
Mov Disord; 2004 Jul; 19(7):770-777. PubMed ID: 15254934
[TBL] [Abstract][Full Text] [Related]
13. [Pathology of paraneoplastic syndromes of the central and peripheral nervous systems and muscle ].
Ferrer I
Rev Neurol; 2000 Dec 16-31; 31(12):1228-36. PubMed ID: 11211860
[TBL] [Abstract][Full Text] [Related]
14. Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Travelstead AL; Longee D
Pediatrics; 2005 Jan; 115(1):e115-9. PubMed ID: 15601813
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulins in paraneoplastic brainstem encephalitis with anti-Ri antibodies.
Fumal A; Jobe J; Pepin JL; Delvaux V; Senterre JM; Bonaventure S; de Noordhout AM
J Neurol; 2006 Oct; 253(10):1360-1. PubMed ID: 17006632
[No Abstract] [Full Text] [Related]
16. Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report.
Salmaggi A; Nemni R; Pozzi A; Silvani A; Forno MG; Luksch R; Confalonieri P; Boiardi A
Tumori; 1997; 83(3):709-11. PubMed ID: 9267493
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of paraneoplastic neurological syndrome].
Inuzuka T
Nihon Ronen Igakkai Zasshi; 2003 May; 40(3):204-9. PubMed ID: 12822462
[No Abstract] [Full Text] [Related]
18. Recent advance in immunological tests in paraneoplastic neurological syndrome.
Fong CS
Acta Neurol Taiwan; 2005 Mar; 14(1):28-35. PubMed ID: 15835287
[TBL] [Abstract][Full Text] [Related]
19. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
20. 6-Mercaptopurine modifies cerebrospinal fluid T cell abnormalities in paediatric opsoclonus-myoclonus as steroid sparer.
Pranzatelli MR; Tate ED; Allison TJ
Clin Exp Immunol; 2017 Nov; 190(2):217-225. PubMed ID: 28710878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
